Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer. Wang R, Xu B, Sun M, Pang X, et al. Eur J Surg Oncol 2023;49:107138.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang R, Xu B, Sun M, Pang X, et al. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer. Eur J Surg Oncol 2023;49:107138.
PMID: 37925830